Reevaluation of the Incidence of Thromboembolic Complications in Congenital Factor XII Deficiency
Authors:
- 1 January 1999
- journal article
- review article
- Published by Georg Thieme Verlag KG in Thrombosis and Haemostasis
- Vol. 82 (10) , 1240-1246
Abstract
To further elucidate the debated role of hereditary FXII deficiency as a thrombophilic risk factor this follow-up study on 65 subjects out of 12 Swiss families was undertaken (follow-up: 6 yrs). Fifteen severely FXII deficient subjects (FXII:C < 1%), 35 partially FXII deficient subjects (FXII:C ≥ 1-59%), 10 with normal FXII values (FXII:C ≥ 70%), and 5 non-classifiable subjects (FXII:C ≥ 60-69%) were reevaluated. Eight subjects (4 severely and 3 partially FXII deficient, 1 non-classifiable) were newly enrolled. Four instances of deep vein thrombosis, one superficial vein thrombosis and one myocardial infarction were noted in 2 out of 19 severely FXII deficient subjects during a total life-time period of 866.6 patient-years. In 38 partially FXII deficient subjects (1862.8 patient-years) one ischemic cerebrovascular stroke and one superficial vein thrombosis were recorded in 2 individuals. The 10 subjects with normal FXII values (498.2 patient-years) remained thrombosis-free. One superficial vein thrombosis occurred in an unclassifiable woman. None of the 3 different FXII gene defects revealed in our patients was specifically associated with thromboembolic complications. Kaplan-Meier analysis of thrombosis-free survival suggests that hereditary partial (and probably severe) FXII deficiency does not constitute a thrombophilic condition. * Supported by grants from the Swiss National Foundation for Scientific Research (No. 32-36443.92 and No. 32-47016.96)Keywords
This publication has 30 references indexed in Scilit:
- The novel acceptor splice site mutation 11396(G->A) in the factor XII gene causes a truncated transcript in cross-reacting material negative patientsHuman Molecular Genetics, 1995
- Prevalence of factor XII (Hageman factor) deficiency among 426 patients with coronary heart disease awaiting cardiac surgeryCoronary Artery Disease, 1994
- Hageman factor and risk of myocardial infarction in middle-aged menAtherosclerosis, 1992
- Factor XII clotting activity and antigen levels in patients with thromboembolic diseaseBlood Coagulation & Fibrinolysis, 1992
- Contact Factors in Health and DiseaseSeminars in Thrombosis and Hemostasis, 1987
- Characterization of a cDNA coding for human factor XII (Hageman factor)Biochemistry, 1986
- Myocardial infarction with normal coronary arteries and factor XII deficiency.Heart, 1985
- Defective intrinsic fibrinolytic activity in a patient with severe factor XII‐deficiency and myocardial infarctionScandinavian Journal of Haematology, 1984
- Arterial and Venous Thrombosis and Normal Response to Streptokinase Treatment in a Young Patient with Severe Hageman Factor DeficiencyActa Haematologica, 1983
- Recurrent Thrombosis in a Patient with Factor XII DeficiencyActa Haematologica, 1980